Catherine Moukheibir
Board member
Toxicology
Drexel University
Austria
Biography
After a career in strategy consulting and investment banking in Boston and London, Catherine Moukheibir has held senior management positions in several European biotech companies. Catherine Moukheibir is Chairman of the Board of MedDay Pharmaceuticals S.A. and a board member of Ablynx S.A. and Cerenis Therapeutics Holding S.A. She is also a member of the Advisory Board at Imperial College Business School, UK.
Research Interest
Drug delivery
